APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,434,062 | -60.2% | 147,465 | -71.2% | 0.03% | -61.2% |
| Q1 2023 | $33,725,480 | +49.5% | 511,302 | +17.2% | 0.08% | +37.1% |
| Q4 2022 | $22,561,073 | -5.9% | 436,300 | +24.3% | 0.06% | -11.4% |
| Q3 2022 | $23,981,000 | +20753.0% | 351,103 | +9940.1% | 0.07% | – |
| Q3 2021 | $115,000 | -99.2% | 3,497 | -98.5% | 0.00% | -100.0% |
| Q2 2021 | $14,994,000 | +563.5% | 237,254 | +350.5% | 0.03% | +600.0% |
| Q1 2021 | $2,260,000 | -66.3% | 52,666 | -55.1% | 0.00% | -71.4% |
| Q4 2020 | $6,706,000 | +15140.9% | 117,230 | +8075.0% | 0.01% | – |
| Q4 2019 | $44,000 | -98.9% | 1,434 | -99.1% | 0.00% | -100.0% |
| Q3 2019 | $3,966,000 | +10916.7% | 164,631 | +11542.9% | 0.01% | – |
| Q2 2019 | $36,000 | +16.1% | 1,414 | -12.1% | 0.00% | – |
| Q1 2019 | $31,000 | +34.8% | 1,609 | -8.3% | 0.00% | – |
| Q4 2018 | $23,000 | -43.9% | 1,755 | -24.3% | 0.00% | – |
| Q3 2018 | $41,000 | -43.8% | 2,317 | -30.4% | 0.00% | – |
| Q2 2018 | $73,000 | +9.0% | 3,327 | +9.3% | 0.00% | – |
| Q1 2018 | $67,000 | – | 3,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |